Pidigi acquires Sympatex, keeps PFAS-free membrane brand and 21 jobs

Pidigi’s move for Sympatex is not just a balance-sheet salvage job. It is a stress test for one of technical fashion’s most closely watched non-toxic materials plays: whether a PFAS-free membrane brand can stay commercially relevant after insolvency, or whether even the most credible sustainable innovation still needs deeper long-term customer commitment to survive.

The Italian materials supplier, Pidigi S.p.A., is taking over Sympatex Technologies GmbH through an asset deal scheduled to take effect on June 1, 2026. The rescued company will continue under the Sympatex name, with Pidigi and a German subsidiary acquiring the core assets and keeping the business alive from its base in Unterföhring, near Munich. Sympatex is best known for waterproof, breathable and recyclable membranes, the kind of ingredient technology that sits quietly inside jackets, shoes and performance gear but increasingly defines how brands talk about environmental progress.

The rescue comes out of a hard winter. Sympatex filed for insolvency with the Munich Local Court on January 22, 2026, citing illiquidity, and the court placed the company under preliminary insolvency administration four days later. At that point, Sympatex said the salaries of all 70 employees were secured through statutory insolvency funds, buying time for a restructuring that has now preserved at least part of the business instead of letting the brand vanish into Germany’s insolvency machinery.

The deal will keep 21 jobs at the Unterföhring site, and all four apprentices are being retained, a small but telling signal in a sector where skilled technical know-how is often the first casualty of distress. Some reports say 25 employees will be made redundant by the end of the month, with effect from the end of August, while around 20 employees had already left voluntarily during the proceedings. That mix of retention and cutbacks underscores the tightrope this rescue is walking: enough continuity to preserve value, not enough slack to pretend the business emerged unscathed.

Pidigi, based in Verona, described itself as an owner-managed Italian supplier and innovation partner to the footwear, leather goods and apparel industries with more than 70 years in the market. The transaction is being framed as an extension of a long-standing collaboration between the two companies, but its significance goes beyond corporate history. The deal is expected to preserve Sympatex’s international footprint in France, China, Hong Kong and South Korea, suggesting that what survives here is not only a German site and a handful of jobs, but one of the few non-toxic membrane options still visible to brands under pressure to clean up their material inputs. In a brutal market, that may be the real measure of viability.